No Longer Accepting Lipitor Cases

Lipitor Causing Type 2 Diabetes Lawsuits

In February 2012, the FDA issued a statement warning consumers that Lipitor and other statins could raise blood sugar levels in some individuals, which could lead to the development of type 2 diabetes.

Following the release of the FDA warning, a new study conducted by the Archives of Internal Medicine suggested that diabetes risk among post-menopausal women who take statins is significantly increased. Although heart disease is far less common in women than it is in men, statistics show that statin use among women is increasing rapidly.

Type 2 Diabetes Symptoms

  • Bladder, kidney, skin, or other infections that are more frequent or heal slowly
  • Fatigue
  • Hunger
  • Increased thirst
  • Increased urination

Lipitor Type 2 Diabetes Lawsuits

Our dangerous drug attorneys can help if you or someone you care about suffered bladder cancer from Lipitor.   Lawsuits have been filed against the drug maker by both patients and their families seeking compensation for injuries caused by this dangerous drug.  You may be entitled to a settlement.

Our No Fee Promise on Lipitor Cases

You can afford to have our great team of lawyers on your side. When you choose us, it literally costs nothing to get started. We promise you in writing:

  • No money to get started
  • We pay all case costs and expenses
  • No legal fees whatsoever unless you receive a settlement
  • Phone calls are always free.

Start Your Lipitor Claim

Our Lipitor lawyers will help you file your lawsuit. To get started, you can:

  1. Submit the Free Case Review Box on this page, or
  2. Call (866) 280-4722 any time of day to tell us about your case.

We will listen to your story and answer your questions. If you have claim, we will start immediately.

WARNING: There are strict time deadlines for filing Lipitor lawsuit claims.

View Sources

Food and Drug Administration. FDA Drug Safety Communication: Important safety label changes to cholesterol-lowering statin drug. Feb 28 2012.

Zaharan NL1, Williams D, Bennett K. Statins and risk of treated incident diabetes in a primary care population. Br J Clin Pharmacol. 2013 Apr;75(4):1118-24. doi: 10.1111/j.1365-2125.2012.04403.x.

Sethi SS1, Farkouh ME. ACP Journal Club. Meta-analysis: Atorvastatin reduces CV events and increases new-onset diabetes in patients with coronary disease. Ann Intern Med. 2013 Jul 16;159(2):JC3. doi: 10.7326/0003-4819-159-2-201307160-02003.

Navarese EP1, Buffon A, Andreotti F, Kozinski M, Welton N, Fabiszak T, Caputo S, Grzesk G, Kubica A, Swiatkiewicz I, Sukiennik A, Kelm M, De Servi S, Kubica J. Meta-analysis of impact of different types and doses of statins on new-onset diabetes mellitus. Am J Cardiol. 2013 Apr 15;111(8):1123-30. doi: 10.1016/j.amjcard.2012.12.037. Epub 2013 Jan 24.

Carter AA1, Gomes T, Camacho X, Juurlink DN, Shah BR, Mamdani MM. Risk of incident diabetes among patients treated with statins: population based study. BMJ. 2013 May 23;346:f2610. doi: 10.1136/bmj.f2610.